Hershey Financial Advisers LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Hershey Financial Advisers LLC bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, Holdings Channel.com reports. The fund bought 2,479 shares of the biotechnology company’s stock, valued at approximately $1,473,000.

A number of other large investors have also recently modified their holdings of AXON. PNC Financial Services Group Inc. boosted its stake in shares of Axon Enterprise by 17.5% during the 3rd quarter. PNC Financial Services Group Inc. now owns 5,627 shares of the biotechnology company’s stock valued at $2,249,000 after purchasing an additional 840 shares in the last quarter. Jennison Associates LLC boosted its stake in shares of Axon Enterprise by 48.2% during the 3rd quarter. Jennison Associates LLC now owns 3,977 shares of the biotechnology company’s stock valued at $1,589,000 after purchasing an additional 1,294 shares in the last quarter. Massachusetts Financial Services Co. MA purchased a new position in Axon Enterprise during the 3rd quarter valued at about $120,553,000. Great Valley Advisor Group Inc. lifted its position in Axon Enterprise by 306.1% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 3,850 shares of the biotechnology company’s stock valued at $1,539,000 after acquiring an additional 2,902 shares during the period. Finally, Penserra Capital Management LLC lifted its position in Axon Enterprise by 12.6% during the 3rd quarter. Penserra Capital Management LLC now owns 6,297 shares of the biotechnology company’s stock valued at $2,516,000 after acquiring an additional 706 shares during the period. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

AXON opened at $560.00 on Monday. The firm has a market cap of $42.91 billion, a P/E ratio of 144.70, a PEG ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a 50 day simple moving average of $591.90 and a two-hundred day simple moving average of $543.57. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Buying and Selling

In related news, Director Jeri Williams sold 307 shares of the company’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Robert W. Baird lifted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Needham & Company LLC reissued a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.